Lead author of the STEP 1 trial, John Wilding, discusses the findings and what they may mean for the treatment of people with obesity. Read the accompanying







STEP 1: Semaglutide for weight loss | John Wilding [xMEXbjUy15C]

STEP 1: Semaglutide for weight loss | John Wilding [xMEXbjUy15C]

| 1h 28m 28s | Video has closed captioning.

Lead author of the STEP 1 trial, John Wilding, discusses the findings and what they may mean for the treatment of people with obesity. Read the accompanying news story: View more on obesity and lifestyle interventions on Medicine Matters diabetes:

Aired: December 12, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now